Estás viendo estas citas basadas en búsquedas anteriores relacionadas con sectores como
Nombre | Valor | Cambio de 1 día | Cambio de 7 día | Cambio de 14 día | Cambio de 30 día | Cambio de 90 día | Beta |
---|---|---|---|---|---|---|---|
4basebio | n / a | 0.00% | 2.39% | 1.90% | 11.46% | 62.12% | n / a |
Farmacia 4D | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Abcam | 134 | 0.00% | - 3.24% | - 2.23% | - 14.03% | - 9.39% | n / a |
Abzená | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n / a |
Agronomía limitada | 475 | 1.19% | 8.97% | 13.33% | - 3.41% | - 15.63% | n / a |
Terapias de alergia | 268 | 1.75% | 1.75% | 1.75% | - 3.33% | 16.00% | n / a |
Alianza Farmacéutica | 119 | - 2.72% | - 5.95% | - 8.72% | - 14.36% | - 13.49% | n / a |
Grupo de cuidado de animales | n / a | 4.15% | 4.15% | 2.73% | 7.62% | 27.32% | n / a |
Anpario | n / a | 1.96% | 4.00% | 6.12% | 13.04% | - 0.95% | n / a |
Grupo Aptamer | n / a | - 16.67% | 11.11% | 42.86% | 30.43% | - 30.23% | n / a |
Aqua Bounty Technologies Inc. (Registro S) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Terapéutica Arecor | n / a | 0.00% | 3.02% | 3.02% | - 2.50% | - 17.27% | n / a |
VPN (DI) de Argent Biopharma Limited | n / a | 2.38% | 2.38% | - 2.27% | - 2.27% | 19.44% | n / a |
AstraZeneca | 123 | 0.30% | 6.88% | 9.07% | 12.61% | 13.78% | n / a |
Grupo Avacta | 461 | - 1.02% | 8.30% | - 6.21% | - 2.91% | - 51.70% | n / a |
Participaciones de referencia | n / a | 0.56% | 2.04% | 4.90% | 1.24% | 5.14% | n / a |
Beximco Pharmaceuticals Ltd. RDA (Reg S) | 190 | 0.00% | - 1.35% | 0.00% | - 6.41% | 4.29% | n / a |
Productos farmacéuticos Biodexa | 386 | 0.00% | - 21.05% | - 31.82% | - 80.26% | - 90.38% | n / a |
Biofrontera AG (DI) | n / a | 0.00% | 1.75% | 1.75% | 1.75% | - 1.69% | n / a |
bioventix | n / a | 0.00% | - 1.66% | - 1.11% | 0.00% | 4.71% | n / a |
Terapéutica BiVictriX | n / a | 0.00% | 0.00% | 2.22% | 2.22% | 0.00% | n / a |
BTG | n / a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n / a |
Participaciones de descubrimiento C4X | n / a | 0.00% | 40.35% | 24.03% | - 9.09% | - 11.44% | n / a |
n / a | 0.00% | 0.00% | 0.00% | 0.00% | - 47.06% | n / a | |
Grupo Chill Brands | 489 | 10.00% | - 15.38% | - 24.14% | - 8.33% | - 22.81% | n / a |
Participaciones de Cizzle Biotechnology | n / a | 0.00% | 0.00% | - 5.71% | - 10.81% | - 34.00% | n / a |
ciprotex | n / a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n / a |
Dechra productos farmacéuticos | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n / a |
Deepverge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Farmacia del destino | 410 | 7.69% | - 23.91% | 0.00% | - 31.37% | - 73.48% | n / a |
Grupo diurno | n / a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n / a |
e-Terapéutica | n / a | - 6.38% | - 10.49% | - 14.25% | - 16.59% | - 48.02% | n / a |
EastPharma Ltd RDA (Reg S) | n / a | 0.00% | - 14.29% | - 60.00% | 9.09% | 9.09% | n / a |
Grupo ECO de Sanidad Animal | n / a | 2.33% | 17.02% | 12.24% | 28.65% | 1.85% | n / a |
Investigación del Edén | n / a | 0.00% | - 12.37% | - 11.46% | - 6.59% | - 28.87% | n / a |
Ergonómico | n / a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n / a |
Faron Pharmaceuticals Oy (DI) | n / a | 9.80% | 16.67% | 12.00% | 1.82% | - 54.25% | n / a |
Futura Médica | 479 | - 1.69% | - 2.11% | - 3.73% | - 13.95% | 15.40% | n / a |
Genflow Biociencias | n / a | 12.68% | 29.03% | 23.08% | 35.59% | 29.03% | n / a |
Género | 128 | 2.65% | 3.24% | 1.14% | 0.96% | - 22.18% | n / a |
GSK | 129 | 1.03% | 1.86% | 1.61% | - 2.26% | 8.89% | n / a |
gunsynd | 527 | 41.67% | 41.67% | 25.93% | 13.33% | 3.03% | n / a |
GW Pharmaceuticals | n / a | 0.00% | - 8.13% | - 7.72% | - 3.35% | 42.30% | n / a |
halcón | n / a | - 0.93% | 0.12% | 2.35% | - 0.54% | 3.32% | n / a |
Productos farmacéuticos Hemogenyx | 340 | - 6.18% | - 4.15% | - 3.19% | - 12.05% | - 41.58% | n / a |
Productos farmacéuticos de Hikma | 125 | 0.89% | 6.16% | 6.81% | 0.60% | 1.79% | n / a |
Grupo de descubrimiento de horizonte | n / a | 0.00% | 0.00% | - 1.34% | - 4.90% | 86.36% | n / a |
HUTCHMED (China) limitada | 226 | 4.83% | 10.14% | 5.92% | 13.64% | 47.93% | n / a |
hvivo | n / a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n / a |
immufarma | 328 | 1.64% | - 8.81% | - 12.65% | 2.35% | 48.97% | n / a |
individuo | 314 | 3.91% | - 2.86% | - 6.87% | - 13.64% | 7.97% | n / a |
Capital inspirado | n / a | 0.00% | - 0.58% | - 0.58% | 0.00% | 12.50% | n / a |
Ixico | n / a | - 5.80% | - 7.14% | - 7.14% | 0.31% | - 20.73% | n / a |
LungLife AI, Inc (DI) | n / a | 7.14% | - 3.23% | - 4.76% | 0.00% | - 27.71% | n / a |
Maxcyte Inc (DI / REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | - 5.13% | n / a |
Grupo Mereo Biopharma | n / a | 0.00% | - 10.17% | - 22.06% | - 18.46% | - 42.39% | n / a |
Motivo Bio | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Farmacia N4 | n / a | 3.23% | - 5.88% | - 5.88% | 23.08% | - 5.88% | n / a |
Nuformix | 322 | 0.00% | - 8.43% | - 7.32% | 0.00% | - 36.67% | n / a |
VAN de Okyo Pharma Limited | 403 | 0.00% | - 31.71% | - 30.00% | - 9.68% | - 74.07% | n / a |
VAN (CDI) de Ondine Biomedical Inc. | n / a | - 6.38% | - 21.43% | - 24.14% | - 40.54% | - 47.62% | n / a |
Salud OptiBiotix | n / a | - 2.82% | - 2.82% | - 10.39% | - 11.99% | - 37.27% | n / a |
Ovoca Bio (CDI) | n / a | 0.00% | 37.50% | 10.00% | 17.86% | - 8.33% | n / a |
Oxford Biomédica | 125 | 13.79% | 22.35% | 28.71% | 29.35% | 43.96% | n / a |
Participaciones de Oxford Cannabinoid Technologies | n / a | 0.00% | 4.29% | - 1.35% | - 15.12% | - 49.66% | n / a |
Tecnologías Oxford Nanopore | n / a | 7.53% | 8.26% | - 2.71% | - 14.24% | - 26.62% | n / a |
Pfizer Inc. | n / a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n / a |
OJSC Pharmstandard RDA (Reg S) | n / a | 0.00% | - 1.75% | 2.89% | - 2.00% | 3.16% | n / a |
Participaciones de Plethora Solutions | n / a | 0.00% | - 11.11% | - 11.11% | 9.09% | - 33.33% | n / a |
Farmacia Poolbeg | n / a | - 5.08% | 9.80% | 12.56% | 13.71% | 34.94% | n / a |
Ciencias del proteoma | 353 | - 13.25% | 10.77% | 15.76% | 6.19% | - 21.74% | n / a |
Salud PureTech | n / a | - 0.46% | 5.60% | 1.64% | - 2.47% | 10.15% | n / a |
Farmacéutica cuántica | n / a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n / a |
Farmacia redx | 278 | 26.67% | - 6.94% | 26.67% | - 38.38% | - 43.00% | n / a |
Grupo ReNeuron | 394 | 0.00% | 0.00% | 0.00% | 0.00% | - 4.93% | n / a |
Participaciones de Sareum | 594 | - 6.67% | 5.38% | 53.13% | 127.91% | - 50.00% | n / a |
Participaciones de Scancell | n / a | - 0.52% | - 0.52% | - 3.05% | - 6.83% | - 9.05% | n / a |
Terapéutica de escudo | n / a | 0.00% | - 5.26% | - 11.48% | - 33.33% | - 77.87% | n / a |
Shire plc | n / a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n / a |
Terapéutica del silencio | 177 | 0.00% | - 1.65% | - 0.93% | 5.94% | - 9.17% | n / a |
Farmacia Sinclair | n / a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n / a |
PielBioTerapéutica | n / a | 0.00% | 0.00% | - 5.13% | - 27.45% | - 16.85% | n / a |
skyepharma | n / a | 0.00% | - 1.94% | - 4.47% | - 6.39% | 17.35% | n / a |
Fuente BioScience | n / a | 0.00% | - 4.11% | - 1.41% | - 1.41% | 2.19% | n / a |
Cumbre Terapéutica | n / a | 0.00% | - 2.38% | - 12.77% | - 2.38% | - 6.82% | n / a |
sinairgen | 510 | 0.15% | - 3.70% | - 2.40% | 27.58% | 13.14% | n / a |
Taiwán | n / a | 0.00% | - 30.00% | 59.09% | - 46.15% | - 72.00% | n / a |
Theracryf | 304 | 6.25% | 6.25% | 9.68% | - 2.86% | - 50.00% | n / a |
Ciencias de la vida de Tiziana | n / a | 0.00% | 11.43% | 12.50% | 7.34% | - 7.87% | n / a |
Valirx | 435 | 0.00% | - 2.90% | - 7.59% | - 5.63% | - 32.32% | n / a |
Grupo Vectura | 139 | 0.00% | 0.12% | - 0.12% | 0.00% | 6.74% | n / a |
Verici DX | 429 | 3.45% | - 6.25% | - 6.25% | - 18.92% | - 21.05% | n / a |
Vernalis plc | n / a | 0.00% | 0.49% | 0.33% | 0.82% | - 4.19% | n / a |
Farmacia Verona | n / a | 0.00% | 4.76% | 4.76% | - 15.38% | - 24.14% | n / a |
Verseon Corporation (DI / REG S) | n / a | 0.00% | 96.72% | 73.91% | - 48.94% | - 67.74% | n / a |
Corporación Verseon (Reg S Cat 3) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Salud de Yourgene | n / a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n / a |